BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36503726)

  • 1. Disparities in hepatocellular carcinoma survival by Medicaid-status: A national population-based risk analysis.
    Kim EJ; Ganga A; Lee JY; Zawadzki RS; Adriance W; Wang R; Cholankeril G; Somasundar PS
    Eur J Surg Oncol; 2023 Apr; 49(4):794-801. PubMed ID: 36503726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
    Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
    J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
    Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
    J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in Primary Spinal Osseous Malignant Bone Tumor Survival by Medicaid Status: A National Population-Based Risk Analysis.
    Ganga A; Kim EJ; Lee JY; Leary OP; Sastry RA; Fridley JS; Chang KE; Niu T; Sullivan PZ; Somasundar PS; Gokaslan ZL
    World Neurosurg; 2024 Jan; 181():e192-e202. PubMed ID: 37777175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance.
    Sellers CM; Uhlig J; Ludwig JM; Taddei T; Stein SM; Lim JK; Kim HS
    Cancer Med; 2019 Oct; 8(13):5948-5958. PubMed ID: 31436905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in primary pancreatic adenocarcinoma survival by Medicaid-status: A national population-based risk analysis.
    Ganga A; Kim EJ; Mintzer GL; Adriance W; Wang R; Cholankeril G; Balkrishnan R; Somasundar PS
    Eur J Surg Oncol; 2023 Jul; 49(7):1242-1249. PubMed ID: 36801151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
    Smartt AA; Jang ES; Tyler WK
    Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in the Receipt of Recommended Curative Treatment for Patients with Early-Stage Hepatocellular Carcinoma.
    Rasic G; de Geus SWL; Papageorge MV; Woods AP; Ng SC; McAneny D; Tseng JF; Sachs TE
    World J Surg; 2023 Jul; 47(7):1780-1789. PubMed ID: 36918443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival.
    Yan M; Ha J; Aguilar M; Bhuket T; Liu B; Gish RG; Cheung R; Wong RJ
    J Hepatol; 2016 Feb; 64(2):326-332. PubMed ID: 26386160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Bridging Locoregional Therapy and Sociodemographics on Survival in Hepatocellular Carcinoma Patients Undergoing Orthotopic Liver Transplantation: A United Network for Organ Sharing Population Study.
    Magnetta MJ; Xing M; Zhang D; Kim HS
    J Vasc Interv Radiol; 2016 Dec; 27(12):1822-1828. PubMed ID: 27692856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma.
    Yu JC; Neugut AI; Wang S; Jacobson JS; Ferrante L; Khungar V; Lim E; Hershman DL; Brown RS; Siegel AB
    Cancer; 2010 Apr; 116(7):1801-9. PubMed ID: 20143441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicaid expansion is associated with a higher likelihood of early diagnosis, resection, transplantation, and overall survival in patients with hepatocellular carcinoma.
    Elshami M; Hoehn R; Hue JJ; Rothermel L; Chavin KD; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
    HPB (Oxford); 2022 Sep; 24(9):1482-1491. PubMed ID: 35370098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
    Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
    Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact.
    Govalan R; Luu M; Lauzon M; Kosari K; Ahn JC; Rich NE; Nissen N; Roberts LR; Singal AG; Yang JD
    Hepatol Commun; 2022 Jan; 6(1):223-236. PubMed ID: 34558830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Uveal Melanoma 5-Year Survival Rates by Medicaid Status: A Nationwide Analysis.
    Kim EJ; Lee JY; Ganga A; Barton A; Rana V; Araia E; Adriance W; Wang R; Somasundar P; Kim LA
    Ophthalmic Epidemiol; 2023 Nov; ():1-7. PubMed ID: 37964586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations.
    Hoehn RS; Hanseman DJ; Dhar VK; Go DE; Edwards MJ; Shah SA
    J Am Coll Surg; 2017 Apr; 224(4):697-704. PubMed ID: 28069526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival disparities by Medicaid status: an analysis of 8 cancers.
    Koroukian SM; Bakaki PM; Raghavan D
    Cancer; 2012 Sep; 118(17):4271-9. PubMed ID: 22213271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer disparities in the context of Medicaid insurance: a comparison of survival for acute myeloid leukemia and Hodgkin's lymphoma by Medicaid enrollment.
    Yung RL; Chen K; Abel GA; Gesten FC; Roohan PJ; Boscoe FP; Sinclair AH; Schymura MJ; Schrag D
    Oncologist; 2011; 16(8):1082-91. PubMed ID: 21873583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.